GE Healthcare, Redbiotec join forces on CMV vaccines; Admedus lifts vaccines stake to 66%;

> Redbiotec and GE Healthcare ($GE) have teamed up on CMV vaccine development and manufacturing. Release

> Admedus has increased its stake in its vaccine development subsidiary past 66%. Report

> Variation Biotechnologies and Paulson Capital have completed their merger; Paulson will now be known as VBI Vaccines. Release

And Finally... The Cancer Treatment Centers of America is slapping Avax with an $5.8M lawsuit over a promise on the latter's cancer vaccine. Report (reg. req.)

Suggested Articles

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.